UBS Group
RXST icon

UBS Group’s RxSight RXST Stock Holding History

UBS Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Buy
1,016,066
+776,610
+324% +$4.69M ﹤0.01% 4184
2026
Q1 		$1.48M Sell
239,456
-385,144
-62% -$3.2M ﹤0.01% 5239
2025
Q4 		$6.51M Sell
624,600
-110,570
-15% -$1.11M ﹤0.01% 3755
2025
Q3 		$6.61M Buy
735,170
+475,395
+183% +$4.17M ﹤0.01% 3746
2025
Q2 		$3.38M Buy
259,775
+178,350
+219% +$2.68M ﹤0.01% 4279
2025
Q1 		$2.06M Sell
81,425
-133,621
-62% -$3.97M ﹤0.01% 4681
2024
Q4 		$7.39M Buy
215,046
+190,885
+790% +$8.61M ﹤0.01% 3399
2024
Q3 		$1.19M Buy
24,161
+5,796
+32% +$297K ﹤0.01% 4501
2024
Q2 		$1.11M Sell
18,365
-13,599
-43% -$777K ﹤0.01% 4331
2024
Q1 		$1.65M Sell
31,964
-2,693
-8% -$132K ﹤0.01% 4131
2023
Q4 		$1.4M Buy
34,657
+16,434
+90% +$482K ﹤0.01% 4187
2023
Q3 		$508K Sell
18,223
-729
-4% -$21.7K ﹤0.01% 4642
2023
Q2 		$546K Buy
18,952
+11,301
+148% +$251K ﹤0.01% 4745
2023
Q1 		$128K Buy
7,651
+2,263
+42% +$32K ﹤0.01% 5731
2022
Q4 		$68.3K Buy
5,388
+4,339
+414% +$52.8K ﹤0.01% 6469
2022
Q3 		$13K Buy
+1,049
New +$14.4K ﹤0.01% 8062
2022
Q2 		– Sell
-3,888
Closed -$48K – 10848
2022
Q1 		$48K Buy
3,888
+282
+8% +$3.39K ﹤0.01% 6540
2021
Q4 		$40K Buy
+3,606
New +$43.3K ﹤0.01% 7124

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group's RXST Position: Q2 2026 in Review

UBS Group increased its RxSight (RXST) stake by 324% in Q2 2026, buying an estimated $4.69M and bringing the position to 1,016,066 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #4184.

UBS Group first reported a position in RXST in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.39M in Q4 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • UBS Group held 1,016,066 shares of RxSight worth $4.9M as of Q2 2026.
  • UBS Group bought 776,610 RxSight shares in Q2 2026, an estimated $4.69M.
  • RxSight made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4184 holding.
  • UBS Group first reported a position in RxSight in Q4 2021 and has held it in 18 quarters since.
  • UBS Group's RxSight position peaked at $7.39M in Q4 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.